{"id":"https://openalex.org/W2907600428","doi":"https://doi.org/10.1111/aos.14008","title":"A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution","display_name":"A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution","publication_year":2019,"publication_date":"2019-01-04","ids":{"openalex":"https://openalex.org/W2907600428","doi":"https://doi.org/10.1111/aos.14008","mag":"2907600428","pmid":"https://pubmed.ncbi.nlm.nih.gov/30609169"},"language":"en","primary_location":{"id":"doi:10.1111/aos.14008","doi":"https://doi.org/10.1111/aos.14008","is_oa":false,"landing_page_url":"https://doi.org/10.1111/aos.14008","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047163157","display_name":"Aika Tsujinaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169016828","display_name":"Shimane University","ror":"https://ror.org/01jaaym28","country_code":"JP","type":"education","lineage":["https://openalex.org/I169016828"]},{"id":"https://openalex.org/I3129591023","display_name":"University of Shimane","ror":"https://ror.org/04m42eq84","country_code":"JP","type":"education","lineage":["https://openalex.org/I3129591023"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Aika Tsujinaka","raw_affiliation_strings":["Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan","institution_ids":["https://openalex.org/I169016828","https://openalex.org/I3129591023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018422527","display_name":"Yasuyuki Takai","orcid":"https://orcid.org/0000-0003-3881-3624","observed_orcids":["https://orcid.org/0000-0003-3881-3624","https://orcid.org/0000-0001-7971-8258"]},"institutions":[{"id":"https://openalex.org/I169016828","display_name":"Shimane University","ror":"https://ror.org/01jaaym28","country_code":"JP","type":"education","lineage":["https://openalex.org/I169016828"]},{"id":"https://openalex.org/I3129591023","display_name":"University of Shimane","ror":"https://ror.org/04m42eq84","country_code":"JP","type":"education","lineage":["https://openalex.org/I3129591023"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuyuki Takai","raw_affiliation_strings":["Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan","institution_ids":["https://openalex.org/I169016828","https://openalex.org/I3129591023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031522859","display_name":"Yoshitsugu Inoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4588055","display_name":"Tottori University","ror":"https://ror.org/024yc3q36","country_code":"JP","type":"education","lineage":["https://openalex.org/I4588055"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitsugu Inoue","raw_affiliation_strings":["Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Yonago, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Yonago, Japan","institution_ids":["https://openalex.org/I4588055"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042536343","display_name":"Masaki Tanito","orcid":"https://orcid.org/0000-0001-6512-7203","observed_orcids":["https://orcid.org/0000-0001-6512-7203"]},"institutions":[{"id":"https://openalex.org/I169016828","display_name":"Shimane University","ror":"https://ror.org/01jaaym28","country_code":"JP","type":"education","lineage":["https://openalex.org/I169016828"]},{"id":"https://openalex.org/I3129591023","display_name":"University of Shimane","ror":"https://ror.org/04m42eq84","country_code":"JP","type":"education","lineage":["https://openalex.org/I3129591023"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masaki Tanito","raw_affiliation_strings":["Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6512-7203","affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Faculty of Medicine, Shimane University, Izumo, Japan","institution_ids":["https://openalex.org/I169016828","https://openalex.org/I3129591023"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042536343"],"corresponding_institution_ids":["https://openalex.org/I169016828","https://openalex.org/I3129591023"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.4499,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78018007,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"97","issue":"6","first_page":"e948","last_page":"e949"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brimonidine-tartrate","display_name":"brimonidine tartrate","score":0.9729999899864197},{"id":"https://openalex.org/keywords/corneal-opacity","display_name":"corneal opacity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/corneal-neovascularization","display_name":"corneal neovascularization","score":0.859000027179718},{"id":"https://openalex.org/keywords/primary-open-angle-glaucoma","display_name":"primary open-angle glaucoma","score":0.8009999990463257},{"id":"https://openalex.org/keywords/glaucoma-medications","display_name":"glaucoma medications","score":0.8149999976158142},{"id":"https://openalex.org/keywords/latanoprost","display_name":"latanoprost","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dorzolamide-timolol","display_name":"dorzolamide/timolol","score":0.9129999876022339},{"id":"https://openalex.org/keywords/bimatoprost","display_name":"bimatoprost","score":0.753000020980835},{"id":"https://openalex.org/keywords/ocular-side-effects","display_name":"ocular adverse effects","score":0.5879999995231628},{"id":"https://openalex.org/keywords/alpha-2-adrenergic-agonists","display_name":"alpha-2 adrenergic agonists","score":0.7540000081062317},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2778190193","wikidata":"https://www.wikidata.org/wiki/Q577377","display_name":"Brimonidine","level":3,"score":0.8580378293991089},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8376282453536987},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7499040365219116},{"id":"https://openalex.org/C2776727336","wikidata":"https://www.wikidata.org/wiki/Q415401","display_name":"Dorzolamide","level":4,"score":0.6633026599884033},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6372944712638855},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.555812656879425},{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.5399870872497559},{"id":"https://openalex.org/C2780276452","wikidata":"https://www.wikidata.org/wiki/Q2193376","display_name":"Travoprost","level":4,"score":0.484164297580719},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.3227441906929016}],"mesh":[{"descriptor_ui":"D000068438","descriptor_name":"Brimonidine Tartrate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068438","descriptor_name":"Brimonidine Tartrate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000072776","descriptor_name":"Slit Lamp Microscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003318","descriptor_name":"Corneal Opacity","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003318","descriptor_name":"Corneal Opacity","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003319","descriptor_name":"Corneal Stroma","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003319","descriptor_name":"Corneal Stroma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016510","descriptor_name":"Corneal Neovascularization","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016510","descriptor_name":"Corneal Neovascularization","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058647","descriptor_name":"Adrenergic alpha-2 Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/aos.14008","doi":"https://doi.org/10.1111/aos.14008","is_oa":false,"landing_page_url":"https://doi.org/10.1111/aos.14008","pdf_url":null,"source":{"id":"https://openalex.org/S21165490","display_name":"Acta Ophthalmologica","issn_l":"0001-639X","issn":["0001-639X","1755-375X","1755-3768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Ophthalmologica","raw_type":"journal-article"},{"id":"pmid:30609169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30609169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta ophthalmologica","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W15413952","https://openalex.org/W2019771909","https://openalex.org/W2331827987","https://openalex.org/W2757404603"],"related_works":["https://openalex.org/W2757404603","https://openalex.org/W3030577310","https://openalex.org/W2946390082","https://openalex.org/W3027139850","https://openalex.org/W2066788868","https://openalex.org/W4415592549","https://openalex.org/W57963654","https://openalex.org/W2030465747","https://openalex.org/W1730268649","https://openalex.org/W2093858516"],"abstract_inverted_index":{"Brimonidine":[0,452],"tartrate":[1,453],"(BT),":[2],"an":[3,90,615],"\u03b12":[4],"adrenergic":[5],"receptor":[6],"agonistic":[7],"ocular":[8,14,152],"hypotensive":[9],"agent,":[10],"is":[11,736],"associated":[12,49,442,687],"with":[13,50,56,260,437,443,561,688,698,755],"side-effects":[15,33],"including":[16,662],"conjunctival":[17,238,379],"injection,":[18],"allergic":[19,164,718],"conjunctivitis":[20,242],"and":[21,89,113,163,185,198,218,240,277,299,303,337,345,356,406,411,429,457,470,490,523,551,554,563,603,606,620,629,638,650,683,714],"blepharitis":[22],"(Manni":[23],"et":[24,28,37,449,572],"al.":[25,29,38,450,573],"2004;":[26],"Kaneko":[27],"2012);":[30],"however,":[31],"corneal":[32,46,232,316,354,363,375,439,519,525,534,581,607,617,622,646,648,652,690,699],"are":[34],"uncommon":[35],"(Shah":[36],"2015).":[39],"We":[40],"report":[41],"a":[42,78,137,579,704,716],"case":[43,643],"of":[44,66,81,85,93,96,140,143,358,372,422,532,541,578,657,675,707,749],"bilateral":[45,57],"opacity":[47,526,535,608,618,623,653],"possibly":[48,441],"BT":[51,116,279,481,516,586,604,639,682,725,734,757],"use.":[52,508,587,726,758],"A":[53],"74-year-old":[54],"man":[55],"primary":[58],"open-angle":[59],"glaucoma":[60],"was":[61,413,446,455,488,495,536,557],"referred":[62],"to":[63,170,245,256,365,506,665,711,738,746],"us":[64],"because":[65,540],"insufficient":[67],"intraocular":[68],"pressure":[69],"(IOP)":[70],"reduction":[71],"in":[72,180,187,212,692],"both":[73],"eyes":[74],"(OU).":[75],"He":[76,135],"had":[77,136,158,644,701],"19-month":[79,138],"history":[80,92,139],"once-daily":[82,261],"topical":[83,444],"instillation":[84,95,142],"0.005%":[86,591,627],"latanoprost":[87,469,562,628],"OU":[88,112,127,217,250,280,318,503,538,560,602],"18-month":[91],"twice-daily":[94,114,269,278],"the":[97,167,173,192,213,282,287,294,313,321,326,331,362,366,370,373,483,510,518,524,530,533,555,630,658,666,689,721,728,740],"1%":[98,270,471,564,631],"dorzolamide":[99,271,472,565,632],"hydrochloride/0.5%":[100,272,473,566,633],"timolol":[101,273,474,567,593,634],"maleate":[102,274,475,568,594,635],"fixed":[103,275,569,595,636],"combination":[104,276,596,637],"(Cosopt,":[105],"Santen":[106,147,461],"Pharmaceutical":[107,148,266,462],"Co.":[108,123,149,267,463],"Ltd.,":[109],"Osaka,":[110,125],"Japan)":[111,126,601],"0.1%":[115,458],"(Aiphagan":[117],"Ophthalmic":[118],"Solution":[119],"0.1%,":[120],"Senju":[121,265],"Pharmaceutical,":[122],"Ltd,":[124],"for":[128,151,400,497,500],"sustained":[129],"IOP":[130,501,556],"over":[131],"20":[132,300,334],"mmHg":[133,196,200,301,335,339,559],"OU.":[134,227,309,377,382,640],"three-times-daily":[141],"0.02%":[144,292],"cyanocobalamin":[145],"(Sancoba,":[146],"Ltd.)":[150,464],"fatigue.":[153],"Other":[154],"than":[155,235],"glaucoma,":[156],"he":[157,290],"no":[159,231,304],"remarkable":[160],"ophthalmological,":[161],"medical":[162,258],"histories.":[165],"At":[166,320,509],"initial":[168,288,314],"presentation":[169],"our":[171,693],"hospital,":[172],"best-corrected":[174],"visual":[175,220,224,283,305],"acuities":[176],"(BCVAs)":[177],"were":[178,194,296,328,333,396,476,548],"0.7":[179],"his":[181,188],"right":[182],"eye":[183,190],"(OD)":[184],"0.6":[186],"left":[189],"(OS);":[191],"IOPs":[193,295,332],"21":[195],"OD":[197,336,550,619],"23":[199],"OS.":[201,340,611],"Bilateral":[202],"gonioscopy":[203],"showed":[204,230,352],"open":[205],"iridocorneal":[206],"angles,":[207],"funduscopy":[208],"typical":[209],"glaucomatous":[210],"changes":[211,385],"optic":[214],"nerve":[215],"heads":[216],"automated":[219],"field":[221,225,306],"analyser":[222],"moderate":[223],"damage":[226],"Slit-lamp":[228,341],"examination":[229,342,421],"pathology":[233],"other":[234,684],"arcus":[236],"senilis,":[237],"injection":[239,380],"follicular":[241,702],"presumably":[243],"due":[244,505],"multiple":[246,659],"antiglaucoma":[247,660,685],"medication":[248],"use":[249,656,674],"(Fig.":[251,343,350,391,544],"1A,B).":[252],"The":[253,378,546,641],"patient":[254],"chose":[255],"continue":[257],"treatment":[259],"0.03%":[262],"bimatoprost":[263],"(Lumigan,":[264],"Ltd.),":[268],"until":[281],"fields":[284],"worsened.":[285],"After":[286],"presentation,":[289,315],"discontinued":[291],"cyanocobalamin;":[293],"between":[297,681],"16":[298,558],"OU,":[302,528],"progression":[307],"occurred":[308],"Ten":[310],"months":[311,479,514],"after":[312,480,515,585,625,654,724],"whitening":[317],"developed.":[319],"scheduled":[322],"11-month":[323],"follow-up":[324],"visit,":[325],"BCVAs":[327,547],"1.0":[329,549],"OU;":[330,486],"18":[338],"1C,D)":[344],"anterior-segment":[346],"optical":[347],"coherence":[348],"tomography":[349],"1E,F)":[351],"marked":[353],"opacities":[355],"invasion":[357],"vascular":[359],"tissues":[360],"from":[361],"limbus":[364],"temporal":[367],"cornea":[368],"at":[369],"level":[371],"deep":[374,438,645],"stroma":[376],"remained":[381],"No":[383],"ischaemic":[384],"(angular":[386],"rubeosis,":[387],"peripheral":[388],"anterior":[389],"synechia)":[390],"1G,H)":[392],"or":[393,679],"retinal":[394],"haemorrhage":[395],"observed.":[397],"Infectious":[398],"keratitis,":[399],"example":[401],"herpesviruses":[402],"(herpes":[403],"simplex":[404],"viruses":[405],"varicella":[407],"zoster":[408],"virus),":[409],"syphilis":[410],"tuberculosis,":[412],"ruled":[414],"out,":[415],"respectively,":[416],"by":[417],"polymerase":[418],"chain":[419],"reaction":[420,719],"tear":[423],"samples,":[424],"Treponema":[425],"pallidum":[426],"hemagglutination":[427],"assay":[428],"tuberculosis":[430],"antigen-specific":[431],"interferon-gamma":[432],"release":[433],"assay.":[434],"Interstitial":[435],"keratitis":[436],"vascularization":[440,484,520],"medications":[445,661,686],"diagnosed":[447],"(Maruyama":[448],"2017).":[451],"(BT)":[454],"discontinued,":[456,489],"betamethasone":[459,487],"(Sanbethasone,":[460],"started":[465],"three":[466,696],"times":[467],"daily;":[468],"continued.":[477],"Three":[478],"discontinuation,":[482,517],"regressed":[485,521],"oral":[491],"acetazolamide":[492],"(500":[493],"mg/day)":[494],"prescribed":[496],"3":[498],"weeks":[499],"elevations":[502],"probably":[504],"steroid":[507,712],"final":[511],"visit":[512],"7":[513],"markedly":[522],"decreased":[527],"while":[529],"extent":[531],"unchanged":[537],"likely":[539,737],"lipid":[542],"deposition":[543],"1I,J).":[545],"1.2":[552],"OS,":[553,605],"combination.":[570],"Maruyama":[571],"(2017)":[574],"reported":[575],"two":[576,668],"cases":[577,697],"severe":[580],"disorder":[582,691],"that":[583,672,709],"developed":[584,609,614],"Patient":[588,612],"1":[589],"used":[590],"latanoprost/0.5%":[592],"(Xalcom,":[597],"Pfizer":[598],"Japan,":[599],"Tokyo,":[600],"nasally":[610],"2":[613],"inferior":[616],"inferotemporal":[621],"OS":[624],"using":[626],"current":[642],"neovascularization,":[647],"infiltration":[649],"limbal":[651],"long-term":[655,673,756],"BT.":[663],"Collectively":[664],"previous":[667],"cases,":[669],"we":[670],"speculate":[671],"BT,":[676,708],"its":[677],"solvent":[678],"interaction":[680],"case.":[694],"All":[695],"disorders":[700],"conjunctivitis,":[703],"well-known":[705],"side-effect":[706],"responded":[710],"therapy":[713],"suggested":[715],"possible":[717,722],"as":[720],"culprit":[723],"However,":[727],"exact":[729],"mechanism(s)":[730],"remains":[731],"unknown.":[732],"Since":[733],"discontinuation":[735],"be":[739,747],"most":[741],"effective":[742],"therapy,":[743],"clinicians":[744],"need":[745],"aware":[748],"this":[750],"disorder,":[751],"which":[752],"rarely":[753],"develops":[754]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-01-11T00:00:00"}